Drug Interaction Software

DRUG INTERACTION SOFTWARE

Predicts drug/drug and drug/food/herb interactions based on P450 metabolism. All medications combined with herbal products and various food items have the potential to interact. The GeneMedRx Drug Interaction Software allows the physician to identify any potential drug/drug and drug/herb/food interaction and helps to establish which drug to reduce, without affecting the blood levels of other medications. For Healthcare Professionals Only.

CURRENT HEALTHCARE SUBSCRIBERS SIGN IN HERE.

HOW IT WORKS

1. Input patient variables such as prescription drugs, over-the-counter items, herbs/foods as well as other factors such as pregnancy and cigarette smoking.

2. Scan the results for potential drug-drug or drug-herb-fod interactions based on the metabolism of the drugs in question. Please note that results do not include the minority of drug-drug interactions for which metabolism is not understood.   

3. Determine the effect removing or adding a particular drug has on the predicted change.   

4. If needed, pick an alternate drug or dosage based on the predicted change profile

VIEW EXAMPLE.

GeneMedRx software is provided for the medical community. Individuals using the drug interaction software should print the report and discuss the results with your physician.

GeneMedRx Software - 1 Year Subscription $175

NOTE: In order to get the group discount - be sure to select
I am a member of a group affiliated with GeneMedRx.
then check the box.

QUESTIONS?  
Contact Genelex Corp. directly at 800-523-3080. Be sure to tell them POINT OF RETURN referred you, so that a group discount can be extended to you.

Genelex is a pioneer in the field of human DNA testing, and was the first company in the world to offer direct-to-consumer DNA drug reaction profiles. Established in 1987, Genelex is a privately held corporation that provides comprehensive DNA testing services to enhance the health and safety of society. Genelex has a worldwide network of contract clients that offer lab services to meet the requirements for any DNA test. POINT OF RETURN has partnered with Genelex Corp. to offer the latest technology in DNA research.

PROGRAM AUTHORS  
Jessica R. Oesterheld, M.D. - a practicing psychiatrist and educator, is a frequent author and lecturer on metabolism-based pharmacology in adults and children. Her interest arose from clinical experiences with adverse drug reactions caused by CYP based drug interactions.  
Neil B. Sandson, M.D. - is Director of the Division of Education and Residency Training at Sheppard Pratt Health System.  
David N. Osser, M.D. - is a clinical psychopharmacology consultant and a member of the International Psychopharmacology Algorithm Project.

DISCLAIMER:

* While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.

*Because these drugs can cause severe withdrawal reactions, do not stop taking any drug without consulting your physician. The decision to quit any medication should be discussed with your doctor.